Volume 3
Archive

Contents

Etiology & Pathogenesis

Yvonne Denkins, Jane Reiland, Madhuchhanda Roy, Neeta D. Sinnappah-Kang, Jennifer Galjour, Brian P. Murry, Jason Blust, Rebecca Aucoin, Dario Marchetti
Brain metastases in melanoma: Roles of neurotrophins
Neuro-Oncology, Volume 6, Number 2, Page 154 – 165. 

German G. Gomez, Susana B. Read, Lazaro E. Gerschenson, Daniela Santoli, Adam Zweifach, Carol A. Kruse
Interactions of the allogeneic effector leukemic T cell line, TALL-104, with human malignant brain tumors
Neuro-Oncology, April 2004, Volume 6, Number 2, Pages 83 – 95 

Overall Management

Alyssa T. Reddy, John C. Wellons III, Jeffrey C. Allen, John B. Fiveash, Hussein Abdullatif, Karen W. Braune, Paul A. Grabb
Refining the staging evaluation of pineal region germinoma using neuroendoscopy and the presence of preoperative diabetes insipidus
Neuro-Oncology, Volume 6, Number 2, Pages 127 – 133. 

Michael Vavra, M. Jaffer Ali, Eric W.-Y. Kang, Yot Navalitloha, Allison Ebert, Cathleen V. Allen, Dennis R. Groothuis
Comparative pharmacokinetics of ¹⁴C-sucrose in RG-2 rat gliomas after intravenous and convection-enhanced delivery
Neuro-Oncology, April 2004, Volume 6, Number 2, Pages 104 – 112. 

Prognosis & Outcome

Daniel J. Brat, Wendy F. Seiferheld, Arie Perry, Elizabeth H. Hammond, Kevin J. M Urray, Alan R. Schulsinger, Minesh P. Mehta, Walter J. Curran
Analysis of 1p, 19q, 9p, and 10q as prognostic markers for high-grade astrocytomas using fluorescence in situ hybridization on tissue microarrays from Radiation Therapy Oncology Group trials
Neuro-Oncology, April 2004, Volume 6, Number 2, Pages 96 – 103.  

Treatment

David A. Larson, Jeffrey M. Suplica, Susan M. Chang, Kathleen R. Lamborn, Michael W. McDermott, Penny K. Sneed, Michael D. Prados, William M. Wara, M. Kelly Nicholas, Mitchel S. Berger
Permanent iodine 125 brachytherapy in patients with progressive or recurrent glioblastoma multiforme
Neuro-Oncology, Volume 6, Number 2, Pages 119 – 126. 

Jennifer A. Quinn, David A. Reardon, Allan H. Friedman, Jeremy N. Rich, John H. Sampson, James Vredenburgh, Sridharan Gururangan, James M. Provenzale, Amy Walker, Holly Schweitzer, Darell D. Bigner, Sandra Tourt-Uhlig, James E. Herndon II, Mary Lou Affronti, Susanne Jackson, Deborah Allen, Karen Ziegler, Cindy Bohlin, Christy Lentz, Henry S. Friedman
Phase 1 trial of irinotecan plus BCNU in patients with progressive or recurrent malignant glioma
Neuro-Oncology, Volume 6, Number 2, Pages 145 – 153. 

David A. Reardon, Jennifer A. Quinn, Jeremy N. Rich, Sridharan Gururangan, James Vredenburgh, John H. Sampson, James M. Provenzale, Amy Walker, Michael Badruddoja, Sandra Tourt-Uhlig, James E. Herndon II, Jeannette M. Dowell, Mary Lou Affronti, Susanne Jackson, Deborah Allen, Karen Ziegler, Steven Silverman, Cindy Bohlin, Allan H. Friedman, Darell D. Bigner, Henry S. Friedman
Phase 2 trial of BCNU plus irinotecan in adults with malignant glioma
Neuro-Oncology, April 2004, Volume 6, Number 2, Pages 134 – 144. 

Weizhen Xu, Anna Janss, Roger J. Packer, Peter Phillips, Joel Goldwein, Thomas M Oshang Jr
Endocrine outcome in children with medulloblastoma treated with 18 Gy of craniospinal radiation therapy
Neuro-Oncology, April 2004, Volume 6, Number 2, Pages 113 – 118.